Browsing publications by Professor Anthony Moorman

Newcastle AuthorsTitleYear
Professor Anthony Moorman
Cytogenetics and outcome of infants with acute lymphoblastic leukemia and absence of MLL rearrangements2014
Dr Lucy Chilton
Professor Christine Harrison
Professor Anthony Moorman
Hyperdiploidy with 49-65 chromosomes represents a heterogeneous cytogenetic subgroup of acute myeloid leukemia with differential outcome.2014
Claire Schwab
Professor Christine Harrison
Professor Anthony Moorman
BTG1 deletions do not predict outcome in Down syndrome acute lymphoblastic leukemia2013
Dr Halima Al-shehhi
Claire Schwab
Dr Amy Erhorn
Dr Alem Gabriel
Professor Christine Harrison
et al.
Abnormalities of the der(12)t(12;21) in ETV6-RUNX1 acute lymphoblastic leukemia2013
Dr Lucy Chilton
Professor Anthony Moorman
Distinct patterns of gained chromosomes in high hyperdiploid acute lymphoblastic leukemia with t(1;19)(q23;p13), t(9;22)(q34;q22) or MLL rearrangements2013
Claire Schwab
Dr Lucy Chilton
Heather Morrison
Lisa Jones
Dr Halima Al-shehhi
et al.
Genes commonly deleted in childhood B-cell precursor acute lymphoblastic leukemia: association with cytogenetics and clinical features2013
Dr Sarah Jenkinson
Professor Anthony Moorman
Impact of NOTCH1/FBXW7 mutations on outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on the MRC UKALL 2003 trial2013
Dr Amir Enshaei
Claire Schwab
Professor Christine Harrison
Professor Anthony Moorman
Long-term follow-up of ETV6-RUNX1 ALL reveals that NCI risk, rather than secondary genetic abnormalities, is the key risk factor2013
Professor Anthony Moorman
Professor Christine Harrison
Loss of chromosomes is the primary event in near-haploid and low-hypodiploid acute lymphoblastic leukemia2013
Professor Anthony Moorman
Claire Schwab
Professor Christine Harrison
Risk-Directed Treatment Intensification Significantly Reduces the Risk of Relapse Among Children and Adolescents With Acute Lymphoblastic Leukemia and Intrachromosomal Amplification of Chromosome 21: A Comparison of the MRC ALL97/99 and UKALL2003 Trials2013
12345678910111213